Golden
Domain Associates

Domain Associates

U.S-based private equity and venture capital firm investing on life science companies.

Domain Associates is a private equity and venture capital firm that focuses on funding startups in the field of life sciences. The firm was founded in 1985 by Jesse I. Treu. Jim Blair has joined the firm since its inception and has remained as one of the firm’s partner as of February 2019. The firm’s current headquarters is located in New Jersey, but it also has offices in San Diego and Philadelphia.

Funding

In the past, the Domain Associates has invested in companies offering their business services in these fields: pharmaceuticals, diagnostics, and medical devices. The firm has also financed companies seeking various stages of funding: from incubation-stage startups to companies already at the stage of emerging growth



As of February 2019, the firm has raised more than $2.8 billion throughout its funding series. Its last funding series was launched in December 2016, and it managed to obtain $163.6 million. In December 2003 and April 2009 respectively, the firm succeeded in acquiring $500 million for each funding series.

Timeline

Funded Companies

47 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

A company focused on development of products to treat central nervous system disorders, pain and rare diseases

Oraya Therapeutics is a biotechnology company developing non-invasive therapies for eye diseases that is headquartered in San Francisco, California and was founded in 2007 by Michael Gertner.

A company developing therapies for inflammation and neurological diseases

A diagnostics company offering genomic tests services

A diagnostics company providing real-time biopsy material to guide personalized medicine for cancer patients

A compant developing nanoscale imaging and analytic platforms to analyze DNA

A life science devices company focused on the discovery and development of protein biomarkers as diagnostic tests

A pharmaceutical company engaged in the discovery, development and commercializtion of antibacterials for the treatment of infections

A biotechnology company focused on the discovery and development of protein therapeutics

A company focused on the discovery and development of treatments for rare inherited diseases.

A company focused on the development proteomics

A molecular diagnostics company that develops testing for infecctious diseases

A pharmacological company that develops PARP inhibitors as cancer therapies

A company that designs and manufactures implantable products to treat presbyopia

A biopharmaceutical company focused on developing therapeutics for the treatment of liver disease, inflammation, fibrosis and HIV

Esperion Therapeutics is an Ann Arbor, Michigan-based company.

A company focused on discovery and development of protein biologics for human therapeutics to treat rare diseases

A biopharmaceutical company focused on developing treatments for inner and middle ear diseases

A biopharmaceutical company developing therapies for the treatment of cancer

A company developing antithrombotic drug systems to treat acute and sub-acute cardiovascular and other indications

A biopharmaceutical company developing ganaxolone for the treatment of drug-resistant seizures and neuropsychiatric disorders

A biotechnology company focused in the development of molecular therapies to treat heart failure

Associated investment funds

2 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Total sold (USD)
Total sold (USD)
Location
Location
Date signed
Date signed

People

Name
Role
LinkedIn

Brian Dovey

Partner



Brian Halak

Partner



Jesse I. Treu

Founder/Partner Emeritus



Jim Blair

Partner



Kim Kamdar

Partner



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Adynxx







Celtaxsys



















References